ePlus

PLUS

Market cap $1.95B

Provides Simplified Operational Support and Increased Visibility Across the Network HERNDON, Va. , Sept. 30, 2025 /PRNewswire/ -- ePlus inc.

Shares of clinical-stage pharmaceutical company, Plus Therapeutics, are up about 31% on a volume spike of 216.4 million

ePlus inc. (NASDAQ:PLUS ) Q1 2026 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Elaine D. Marion - Chief Financial Officer Kleyton L.

HERNDON, Va., Sept. 15, 2025 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS – news) today announced the following conference participation

Transaction Enhances ePlus' AI-Powered Solutions Portfolio HERNDON, Va. , Sept. 10, 2025 /PRNewswire/ -- ePlus inc.

ePlus inc. (NASDAQ:PLUS ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Elaine D. Marion - Chief Financial Officer Kleyton L.

ePlus inc. delivered a blowout Q1 FY26, beating top and bottom line estimates, and boosted its balance sheet by divesting its financing segment. Strategic focus on high-margin tech services, AI, and cybersecurity, plus accretive acquisitions, positions ePlus for sustained growth and margin expansion. ePlus initiated a share buyback and first-ever $0.25 quarterly dividend, signaling confidence in free cash flow and enhancing shareholder value.

ePlus (PLUS) Q1 Revenue Jumps 19%

ePlus (PLUS) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.13 per share a year ago.

~ Announces Initial Common Stock Quarterly Dividend of $0.25 Per Share and New Stock Repurchase Program ~ First Quarter Fiscal Year 2026 Consolidated net sales increased 19.0% to $637.3 million from last year's first quarter; services revenues increased 48.8% to $116.3 million. Gross billings increased 14.3% to $952.8 million.